Clinical trial
Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
NCT01597557 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
- Lead sponsor
- State University of New York at Buffalo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- February 28, 2014
- Enrollment
- 261 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.